"Global Genetic Testing Market Forecast to 2015", provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principal, types and Direct-to-Consumer (DTC) business methodology is also covered in around 140-page report. On account of our analysis of the past and present market trends, drivers, and existing strengths and challenges, forecast for genetic testing has been drawn, according to which, the market is likely to grow at a CAGR of around 26% during 2012-2015.
The report effectively illustrates the role of genetic testing in diseases, such as Cancer, Cystic Fibrosis, and Alzheimer. It also incorporates the information on disease prevalence, available tests, and genes that cause a particular disease. An extensive research and reliable statistics in terms of market size, developments and future performance for emerging sectors namely: Next-Generation Sequencing and Genomic Biomarkers are found inside the report.
The report provides comprehensive analytics of key developments for major markets including the US, Canada, the UK, and Germany. These key developments are likely to set the future of genetic testing market in these countries and that is precisely the reason behind their incorporation in the report.
The report also profiles the eight most active genetic testing market players worldwide: Abbott Laboratories, Beckman Coulter, Roche Diagnostics, Myriad Genetics, Life Technologies, Genomic Health, Sequenom, Transgenomic, Dako, Gen-Probe, Quest Diagnostics, Genoptix and Clarient. For the purpose of effective competitive analysis of the market, these companies are analyzed on five major areas namely: business overview, product offering; financial performance for the last three years, strategic analysis of strengths and weaknesses and key developments.